findmyKOL
Clinical trialNCT02466867CompletedPhase 4Interventional

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

SponsorMerz North America, Inc.Enrollment27Tinea Corporis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an open label, multi-center, multi-application pharmacokinetic study in pediatric subjects with tinea corporis.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Dominican Republic
  • Merz Investigative Site#180001

    Santo Domingo, Dominican Republic

Honduras
  • Merz Investigative Site #504001

    San Pedro Sula, Honduras

United States
  • Merz Investigative Site#001261

    College Station, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Naftin® Cream, 2%
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2014
Primary completion
31 Oct 2015
Completion
31 Dec 2015
Last update posted
28 Oct 2016
Registered enrollment
27
Registry id
NCT02466867
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.